NCT02207439 2023-07-25Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckAbramson Cancer Center at Penn MedicinePhase 2 Completed18 enrolled 9 charts